The global bio-based propylene glycol market is witnessing remarkable growth, driven by sustainability trends and rising demand from pharmaceutical, food, and industrial sectors. Valued at USD 289.25 million in 2024, the market grew to USD 321.8 million in 2025 and is projected to reach approximately USD 837.57 million by 2034, expanding at a CAGR of 11.25% (2025–2034).
This article explores the market size, regional dynamics, leading companies, and answers key FAQs for a comprehensive overview.
The shift towards renewable raw materials and eco-friendly processes is fueling the adoption of bio-based propylene glycol (bio-PG). Its wide application as a pharmaceutical excipient, food additive, and industrial solvent strengthens its market position globally. Emerging technologies like 3D printing and the integration of AI/ML in R&D are accelerating demand.
North America: Accounted for 35% of revenue in 2024, thanks to strong pharmaceutical and food industries.
Asia-Pacific: Expected to be the fastest-growing region, driven by industrial expansion and environmental initiatives.
Europe: Emphasizes green chemistry, supporting bio-PG adoption in various sectors.
About: ADM is a global leader in agricultural origination and processing.
Products: Their bio-based chemicals portfolio includes sustainable propylene glycol derived from glycerin.
Market Cap: Approx. USD 45 billion.
About: A German multinational and one of the largest chemical producers globally.
Products: BASF focuses on high-performance, bio-based solutions, including propylene glycol for cosmetics and pharma.
Market Cap: Approx. USD 45–50 billion.
About: A U.S. giant in chemicals, materials, and specialty products.
Products: Dow manufactures bio-based glycols serving the automotive, pharmaceutical, and food sectors.
Market Cap: Approx. USD 38 billion.
About: A Hong Kong-based bio-chemical enterprise.
Products: Specializes in bio-chemicals like propylene glycol derived from renewable resources.
Market Cap: Approx. USD 1 billion.
About: A Dutch-domiciled multinational chemical company.
Products: Offers bio-PG for industrial and consumer applications.
Market Cap: Approx. USD 35 billion.
About: A joint venture between DuPont and Tate & Lyle.
Products: Produces Susterra® propanediol, a bio-based alternative to propylene glycol.
Market Cap: (Parent DuPont) Approx. USD 36 billion.
About: European leader in oleochemistry.
Products: Manufactures bio-based glycols for food and pharma.
Market Cap: (Parent Avril) Private.
About: A U.S. multinational with a diverse portfolio in food and bio-industrial products.
Products: Supplies bio-PG derived from plant-based feedstocks.
Market Cap: Private, estimated annual revenue $177 billion.
About: An Indian petrochemical company and a key player in glycols.
Products: Offers sustainable alternatives in propylene glycol production.
Market Cap: Approx. USD 350 million.
About: Spanish energy and petrochemical giant.
Products: Focuses on bio-based derivatives, including propylene glycol.
Market Cap: Approx. USD 21 billion.
By Source:
Glycerin segment dominates with a 48% market share in 2024.
By Application:
Strong demand from pharmaceutical, food & beverage, and industrial sectors.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
It is widely used in pharmaceutical excipients, food additives, cosmetics, and industrial lubricants due to its eco-friendly profile.
North America led in 2024 with a 35% share, while Asia-Pacific is expected to show the fastest growth.
Key players include ADM, BASF SE, Dow Chemical, Cargill, and DuPont Tate & Lyle Bio Products.
Sustainability trends, increased drug discovery research, and 3D printing applications are major growth drivers.
The market is expected to reach around USD 837.57 million by 2034.
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5856
Source : https://www.towardshealthcare.com/insights/bio-based-propylene-glycol-market-sizing
The global home healthcare market, valued at USD 208.95 billion in 2024, is projected to reach USD 476.80 billion by… Read More
The global microbiology testing market was valued at USD 5.84 billion in 2024, grew to USD 6.37 billion in 2025,… Read More
The global digital pathology market was valued at USD 1.14 billion in 2024, grew to USD 1.23 billion in 2025,… Read More
The global medical membrane market was valued at USD 4.26 billion in 2024, grew to USD 4.58 billion in 2025,… Read More
The global healthcare biometrics market was valued at USD 8.4 billion in 2024, projected to reach USD 9.86 billion in… Read More
The global human microbiome market was valued at USD 0.94 billion in 2024, projected to reach USD 1.23 billion in… Read More